Evidence map›Paper›PMID 30183269›Full record

ArticleBiochemistry2018

Mycofactocin Biosynthesis Proceeds through 3-Amino-5-[( p-hydroxyphenyl)methyl]-4,4-dimethyl-2-pyrrolidinone (AHDP); Direct Observation of MftE Specificity toward MftA.

Richard Ayikpoe, Joe Salazar, Brian Majestic, John A Latham

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 27 citations in OpenAlex.

  1. Protein Architecture and Composition in Mycobacterium tuberculosis.Advances in experimental medicine and biology · 2026
    Review
  2. Article
  3. Article
  4. ACS chemical biology · 2022
    Article
  5. Review
  6. Article
  7. Impact of Oxygen Supply and Scale Up onFrontiers in bioengineering and biotechnology · 2020
    Article
  8. Article
  9. Article
  10. Occurrence, function, and biosynthesis of mycofactocin.Applied microbiology and biotechnology · 2019
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Richard AyikpoeDepartment of Chemistry and Biochemistry , University of Denver , Denver , Colorado 80208 , United States.
Joe SalazarDepartment of Chemistry and Biochemistry , University of Denver , Denver , Colorado 80208 , United States.
Brian MajesticDepartment of Chemistry and Biochemistry , University of Denver , Denver , Colorado 80208 , United States.
John A LathamDepartment of Chemistry and Biochemistry , University of Denver , Denver , Colorado 80208 , United States.ORCID 0000-0002-3034-1768
University of Denver · US

Funding

Elucidating the biosynthesis of mycofactocin, an unknown molecule essential for M. tuberculosisR01GM124002 · NIGMS · UNIVERSITY OF DENVER (COLORADO SEMINARY) · PI EATON, SANDRA S. · 2017 to 2021
$1.6M
NIGMS NIH HHS R01 GM124002
6 · The paper itself

Abstract

The structure of the ribosomally synthesized and post-translationally modified peptide product mycofactocin is unknown. Recently, the first step in mycofactocin biosynthesis was shown to be catalyzed by MftC in two S-adenosylmethionine-dependent steps. In the first step, MftC catalyzes the oxidative decarboxylation of the MftA peptide to produce the styrene-containing intermediate MftA**, followed by a subsequent C-C bond formation to yield the lactam-containing MftA*. Here, we demonstrate the subsequent biosynthetic step catalyzed by MftE is specific for MftA*. The hydrolysis of MftA* leads to the formation of MftA(1-28) and 3-amino-5-[( p-hydroxyphenyl)methyl]-4,4-dimethyl-2-pyrrolidinone (AHDP). The hydrolysis reaction is Fe

Indexed as

Bacterial ProteinsMolecular ChaperonesMycobacteriumProtein O-MethyltransferasePyrrolidinonesS-AdenosylmethionineBacterial ProteinsMolecular ChaperonesProtein O-MethyltransferasePyrrolidinonesS-Adenosylmethionine

Identifiers

PMID30183269
PMCPMC6143433
OpenAlexW2891089323

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.